BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 27, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 21, 2008
View Archived Issues
Positive results emerge from phase III ALO-01 study in patients with osteoarthritis pain
Read More
rhEPO shows clinical benefits for the treatment of amyotrophic lateral sclerosis
Read More
Cenomed reports on new schizophrenia and posttraumatic stress disorder candidates
Read More
Mutation-specific effects seen with pyrimethamine in familial ALS patients
Read More
Novel means of avoiding opioid-related adverse events reported in recent Progenics patent
Read More
Recent GenkyoTex patent imparts novel therapeutics for cardiovascular disorders
Read More
New antiinflammatory agents reported in recent Biolipox patents
Read More
Alizyme presents update on clinical development activities between July and November 2008
Read More
FDA reschedules Advisory Committee meeting with Novo for liraglutide until April 2009
Read More
Memory completes enrollment in phase II trial of MEM-3454 in CI associated with schizophrenia
Read More
CytRx updates progress of third quarter 2008
Read More
Chelsea Therapeutics completes enrollment in phase II trial of droxidopa in IDH
Read More
GenVec reports interim results from phase III PACT trial of TNFerade
Read More
Phase III studies show vandetanib offers benefit to patients with lung cancer
Read More
BioDelivery Sciences to resubmit REMS for Onsolis to FDA in December 2008
Read More
Karo Bio and Wyeth extend drug discovery collaboration with LXR in inflammatory diseases
Read More
BI-201335 well tolerated, active in treatment-naive and -experienced HCV patients
Read More
Hyperphosphatemia controlled with fermagate in hemodialysis patients
Read More
Elixir's reports results from phase III trial of metformin-mitiglinide therapy
Read More
Telavancin receives favorable recommendation from FDA
Read More
Cougar Biotechnology commences phase I/II CB-7630 trial in breast cancer
Read More
Ortho Biotech submits NDA for trabectedin for relapsed ovarian cancer
Read More
Debiopharm and Aurigene sign licensing agreement for Debio-0617
Read More
Grazax approved in Europe for children with hay fever
Read More
Basilea's Zevtera receives positive opinion from the CHMP
Read More
GlaxoSmithKline receives FDA accelerated approval for Promacta
Read More
